RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF
申请人:ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
公开号:US20150166492A1
公开(公告)日:2015-06-18
Compounds, compositions and methods are provided for selectively activating chaperone-mediated autophagy (CMA), protecting cells from oxidative stress, proteotoxicity and lipotoxicity, and/or antagonizing activity of retinoic acid receptor alpha (RARα) in subjects in need thereof.
本发明提供了一种选择性激活伴随蛋白介导的自噬(CMA),保护细胞免受氧化应激、蛋白毒性和脂毒性的化合物、组合物和方法,并/或在需要的受试者中拮抗视黄酸受体α(RARα)的活性。